Literature DB >> 22843884

Improved gene transfer into bladder cancer cells using adenovirus vector containing RGD motif.

Kazuhiro Hiwasa1, Hisao Nagaya, Shuji Terao, Bishnu Acharya, Katsuyuki Hamada, Hiroyuki Mizuguchi, Akinobu Gotoh.   

Abstract

BACKGROUND: The transduction efficacy of adenovirus serotype 5 (Ad5) vector in high-grade human bladder cancer cells is generally extremely low due to the non-expression of coxsackie and adenoviral receptor (CAR). We investigated whether fiber-modified adenovirus vector containing an RGD motif in the HI loop of the adenovirus fiber knob could increase the transduction efficiency of Ad5 into human bladder cancer cells in vitro.
MATERIALS AND METHODS: We examined the expressions of CAR, and of α(v), β(3) and β(5) integrin, and the transduction efficacy of fiber-modified adenovirus vector in four human bladder cancer cell lines (TCC-SUP, 253J, T24 and KK47).
RESULTS: The expression of CAR was lower and those of α(v) and β(3) integrin were higher in four human cancer cell lines compared with the control cell line, KK47. The transduction efficacy of fiber-modified adenovirus vector increased by 20- to 470-fold compared with Ad5.
CONCLUSION: Fiber-modified adenovirus vector may be useful in order to establish new effective gene therapy strategies for the treatment of high-grade human bladder cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22843884

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  Magnetic nanoparticles as a new approach to improve the efficacy of gene therapy against differentiated human uterine fibroid cells and tumor-initiating stem cells.

Authors:  Shahinaz Mahmood Shalaby; Mostafa K Khater; Aymara Mas Perucho; Sara A Mohamed; Inas Helwa; Archana Laknaur; Iryna Lebedyeva; Yutao Liu; Michael P Diamond; Ayman A Al-Hendy
Journal:  Fertil Steril       Date:  2016-03-25       Impact factor: 7.329

2.  RGD-modifided oncolytic adenovirus exhibited potent cytotoxic effect on CAR-negative bladder cancer-initiating cells.

Authors:  Y Yang; H Xu; J Shen; Y Yang; S Wu; J Xiao; Y Xu; X-Y Liu; L Chu
Journal:  Cell Death Dis       Date:  2015-05-14       Impact factor: 8.469

Review 3.  The evolution of adenoviral vectors through genetic and chemical surface modifications.

Authors:  Cristian Capasso; Mariangela Garofalo; Mari Hirvinen; Vincenzo Cerullo
Journal:  Viruses       Date:  2014-02-17       Impact factor: 5.048

4.  Construction of a pIX-modified Adenovirus Vector Able to Effectively Bind to Nanoantibodies for Targeting.

Authors:  M N Garas; S V Tillib; O V Zubkova; V N Rogozhin; T I Ivanova; L A Vasilev; D Yu Logunov; M M Shmarov; I L Tutykhina; I B Esmagambetov; I Yu Gribova; A S Bandelyuk; B S Naroditsky; A L Gintsburg
Journal:  Acta Naturae       Date:  2014-04       Impact factor: 1.845

5.  Nonmuscle invasive bladder cancer: a primer on immunotherapy.

Authors:  Mahir Maruf; Sam J Brancato; Piyush K Agarwal
Journal:  Cancer Biol Med       Date:  2016-06       Impact factor: 4.248

6.  Ruguo key genes and tumor driving factors identification of bladder cancer based on the RNA-seq profile.

Authors:  Minglei Zhang; Hongyan Li; Di Zou; Ji Gao
Journal:  Onco Targets Ther       Date:  2016-05-05       Impact factor: 4.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.